Disclosure statement
No conflicts of interests are reportable. Grants and honoraries unrelated to this paper were disclosed in COI statement for each author.
Leukemia & Lymphoma
Volume 61, 2020 - Issue 10
Commentaries
Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns
, 
&
Monica SlavinDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australiahttps://orcid.org/0000-0002-8443-314X
https://orcid.org/0000-0002-8443-314X & Benjamin W. TehDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia;National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australiahttps://orcid.org/0000-0003-0213-5470
https://orcid.org/0000-0003-0213-5470![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})